Mesa Laboratories MLAB Clinical Genomics — Goodwill Foreign Currency Translation Gain Loss

Other segment segments

Similar metrics at other companies

PSNCritical Infrastructure — Goodwill Foreign Currency Translation Gain Loss

-$1.2M-149%

STZConstellationwinesandspirits — Goodwill Foreign Currency Translation Gain Loss

$43.3M—

IDTNet2phone — Goodwill Foreign Currency Translation Gain Loss

$19.25K+450%

RHRH — Goodwill Foreign Currency Translation Gain Loss

$3K-94.9%

LSAKConsumer — Goodwill Foreign Currency Translation Gain Loss

$256K+138%

LSAKEnterprise — Goodwill Foreign Currency Translation Gain Loss

$584K—

FAQ

What is Mesa Laboratories's clinical genomics — goodwill foreign currency translation gain loss?

Mesa Laboratories (MLAB) reported clinical genomics — goodwill foreign currency translation gain loss of $39K in Q2 2026.

How has Mesa Laboratories's clinical genomics — goodwill foreign currency translation gain loss changed year-over-year?

Mesa Laboratories's clinical genomics — goodwill foreign currency translation gain loss decreased by 71.1% year-over-year, from $135K to $39K.

What is the long-term trend for Mesa Laboratories's clinical genomics — goodwill foreign currency translation gain loss?

Over 2 years (2023 to 2026), Mesa Laboratories's clinical genomics — goodwill foreign currency translation gain loss has grown at a 100.0% compound annual growth rate (CAGR), from $49K to $196K.

What does clinical genomics — goodwill foreign currency translation gain loss mean?

This captures the impact of fluctuations in foreign exchange rates on the carrying value of goodwill denominated in non-functional currencies within the Clinical Genomics segment. It is a non-cash adjustment that reflects the volatility of international operations rather than operational performance.